Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $48.55 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 8.2× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 92 Days on average.
| KYMR | VTIP | |
|---|---|---|
Market Cap | $8.88B | $73.20B |
Volume | 1,028,790 | 3,980,495 |
Sector | Health | — |
52-Week High | $127.31 | $50.46 |
52-Week Low | $55.80 | $48.38 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $8.27B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $48.46, down slightly by 0.06% on the day. The technical picture is bearish based on moving averages, with oscillators neutral. Recent news highlights its role as an inflation hedge amid rising energy prices and Fed rate hikes, with institutional buying noted. Key support is at $48, resistance at $49.
The outlook for VTIP is cautious; it offers inflation protection but faces headwinds from persistent high rates. Risks include interest rate sensitivity and inflation volatility. Analyst sentiment is mixed, with some seeing value in short-duration TIPS, but the bearish technical trend suggests near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
